Aims and Scope
The International Journal of Gerontology (IJGE) is the official peer-reviewed and SCIE-indexed journal of the Taiwan Society of Geriatric Emergency and Critical Care Medicine. It is published quarterly by Elsevier. The Journal aims to publish original research and review papers on all fields of geriatrics and gerontology, including those dealing with critical care and emergency medicine.
The IJGE aims to explore and clarify the medical science and philosophy in all fields of geriatrics and gerontology, including those in the emergency and critical care medicine. The IJGE is determined not only to be a professional journal in gerontology, but also a leading source of information for the developing field of geriatric emergency and critical care medicine. It is a pioneer in Asia.Topics in the IJGE cover the advancement of diagnosis and management in urgent, serious and chronic intractable diseases in later life, preventive medicine, long-term care of disability, ethical issues in the diseased elderly and biochemistry, cell biology, endocrinology, molecular biology, pharmacology, physiology and protein chemistry involving diseases associated with age. We did not limit the territory to only critical or emergency condition inasmuch as chronic diseases are frequently brought about by inappropriate management of acute problems.
The scientific information published here is grounded on clinical cases, statistic evidence of original studies, and accumulation of medical knowledge, humanistic ethics and basic researches. We are also interested in studies bridging the gap between basic and clinical aspects of geriatric diseases. In addition to Review and Original articles, Brief communications, Case reports, Medical images and Letters to the editor are also welcome.The IJGE is an open access journal and is indexed in the SCIE since its first volume. It is also indexed in SCOPUS, Embase, ScienceDirect, CAB Abstract & Global Health and SIIC Data Bases.
The Editorial Board requires authors to be in compliance with the Uniform Requirements for Manuscripts Submitted to Biomedical Journals (URMs), which are compiled by the International Committee of Medical Journal Editors (ICMJE); current URMs are available at http://www.icmje.org/.These Instructions to Authors are revised periodically by the Editors as needed. Authors should visit this page for the latest version of these instructions. Any manuscript not prepared according to these instructions will be returned immediately to the author(s) without review.
The categories of articles that are published in the Journal are listed and described below. Please select the category that best describes your paper. If your paper does not fall into any of these categories, please contact the Editorial Office.
The Introduction should provide a brief background to the subject of the paper, explain the importance of the study, and state a precise study question or purpose.The Materials and Methods section should describe the study design and methods (including the study setting and dates, patients/participants with inclusion and exclusion criteria, patient samples or animal specimens used, the essential features of any interventions, the main outcome measures, the laboratory methods followed, or data sources and how these were selected for the study), and state the statistical procedures employed in the research. This section must also include a statement regarding approval of the study by an institutional review board and informed consent from human subjects where applicable.
The Results section should comprise the study results, including numeric data and the results of statistical analyses, presented in a logical sequence, supplemented by tables and/or figures. Take care that the text does not repeat data that are presented in tables and/or figures. Rather than simply stating numerical results, the text in this section should interpret the data; only emphasize and summarize the essential features of the main results.
The Discussion should begin with a clear statement of the major findings of the study and their implications. The findings should be compared with those of other relevant reports. Limitations of the study should be noted. The conclusion should emphasize the important implications of the study, but only as supported by the actual results. Comments about specific future directions may be made as appropriate, e.g., work still needed to translate bench findings into clinical applications or particular studies needed to advance understanding of the topic. Avoid, however, vague calls for further studies. Material in the Introduction should not be repeated in the Discussion, nor should specific study results be repeated except as necessary to emphasize a specific point.
Short CommunicationsThese reports should be concise presentations of clinical observations or preliminary experimental results or technical aspects of clinical or experimental practice that are not fully investigated, verified or perfected but which may be of widespread interest or application. The Editors reserve the right to determine what constitutes a Short Communication.
These are short discussions of a case or case series with unique features not previously described that make an important teaching point or scientific observation. They may describe novel techniques or use of equipment, or new information on diseases of importance. Section headings should be: Abstract, Introduction, Case Report, Discussion, Acknowledgments (if any), and References.The Abstract should include a brief statement of the background, age and sex of the patient(s), clinical findings, and management and outcome.
The Introduction should describe the purpose of the present report, the significance of the disease and its specificity, and briefly review the relevant literature.The Case Report should include a focused patient history, physical examination, and results of diagnostic studies, the definitive diagnosis, treatment and outcome, and any other information pertinent to the case(s).
The Discussion should begin with a clear statement of the main point(s) illustrated by the case(s), along with reference to relevant reports in the literature. The focus should be on the particular points the authors wish to make but should not include a textbook review of the entire disease entity.Format guide
Medical imagery are interesting and classic images of medical issues related to gerontology. They are important to facilitate learning and understanding in both basic research and clinical medicine. This category aims to feature medical images with novelty, innovation and an educational sense in any field of gerontology, especially images from emergency and critical situations. It is not intended to be another form of case report.Images must be original and of high quality to be considered for publication. The figure can have up to 3 photographs or images, and should include appropriate labeling and arrows identifying specific structures. All labeled structures in the image(s) should be accurately described and explained in the figure legend. Relevant clinical information, including a short description of the patient's history, physical and laboratory findings, and clinical course should also be succinctly presented in the figure legend.
Letters are welcome in response to previously published IJGE articles, and may also include interesting cases that do not meet the requirement of being truly exceptional, as well as other brief technical or clinical notes of general interest. Letters should have a title, include appropriate references and the corresponding author's mailing and e-mail addresses. Letters are edited, sometimes extensively, to sharpen their focus. They may be sent for peer review at the discretion of IJGE Editors. Letters are selected based on clarity, significance, and space.Format guide
Before submitting your manuscript to the journal, you may consider the use of a professional language editing service, particularly if English is not your first language. Although editing prior to submission is not mandatory, it may improve the overall quality of your manuscript and enable journal editors and reviewers to fully understand the content of your paper. The use of a professional language-editing service does not guarantee that your manuscript will receive a favorable response from IJGE.
Note that several other companies also offer language editing services, and authors can choose from any of these. IJGE does not accept responsibility for costs associated with the use of an independent editing service provider services or the associated customer service support.Online Submission
Manuscripts (meaning all submission items, including all text, tables, artwork, cover letter, authorship statement and conflicts of interest disclosures, and any other required documents/material) must be submitted online to the IJGE through EVISE at https://www.evise.com/profile/api/navigate/null. If assistance is required, please refer to the tutorials for authors and/or customer support that are available on the EVISE website; you may also contact the Editorial Office. Please do not post, fax or e-mail your manuscripts to the Editorial Office.Editorial Office
International Journal of Gerontology (IJGE)
12 Floor - 14, No. 42, Sec. 1, Min-Sheng East Road, Taipei 10446, Taiwan
Tel: (+886) 2 2543-3555
Fax: (+886) 2 2543-1989
The following documents must be included in your submission (refer also to the Checklist). Items (1), (2) and (3) are mandatory. Items (4), (5) and (6) are required only if they are applicable to your manuscript.
This must include the following information:
2.Authorship & Conflicts of Interest Statement.
Each author's contribution to the manuscript should be listed. Any and all potential and actual conflicts of interest should also be listed. Please use the IJGE Authorship & Conflicts of Interest Statement form. Your signature and those of ALL your coauthors must be included.
In the event that your manuscript is accepted for publication in the IJGE, you are required to transfer all copyright ownership in and relating to the work to the Taiwan Society of Geriatric Emergency and Critical Care Medicine. Please use the IJGE Copyright Transfer Agreement form. Your signature and those of ALL your coauthors must be included. However, the Agreement will be null and void if your manuscript is not published in the IJGE.
Articles covering the use of human or animal samples in research, or human or animal experiments must be accompanied by a letter of approval from the relevant review committee or authorities.
Articles where human subjects can be identified in descriptions, photographs or pedigrees must be accompanied by a signed statement of informed consent to publish (in print and online) the descriptions, photographs and pedigrees from each subject who can be identified.
If you have reproduced or adapted material from other copyrighted sources, the letter(s) of permission from the copyright holder(s) to reproduce or adapt the copyrighted sources must be supplied. Otherwise, such material must be removed from your manuscript.
A conflict of interest occurs when an individual's objectivity is potentially compromised by a desire for financial gain, prominence, professional advancement or a successful outcome. IJGE Editors strive to ensure that what is published in the Journal is as balanced, objective and evidence-based as possible. Since it is difficult to distinguish between an actual conflict of interest and a perceived conflict of interest, the Journal requires authors to disclose all and any potential conflicts of interest.Conflicts of interest may be financial or non-financial. Financial conflicts include financial relationships such as honoraria; educational grants; participation in speakers' bureaus; membership, employment, consultancies, stock ownership, or other equity interest; expert testimony or patent-licensing arrangements. Non-financial conflicts include personal or professional relationships, affiliations, academic competition, intellectual passion, knowledge or beliefs that might affect objectivity.
Please ensure that the name of each author listed in your manuscript appears in either Section I or Section II on page 2 of the IJGE Authorship & Conflicts of Interest Statement form (an author's name cannot appear in both Section I and Section II of the form).Ethical Approval of Studies and Informed Consent
For human or animal experimental investigations, appropriate institutional review board or ethics committee approval is required, and such approval should be stated in the methods section of the manuscript. For those investigators who do not have formal ethics review committees, the principles outlined in the Declaration of Helsinki should be followed (World Medical Association. Declaration of Helsinki: ethical principles for medical research involving human subjects. Available at: http://www.wma.net/en/30publications/10policies/b3/17c.pdf).For investigations in humans, state explicitly in the methods section of the manuscript that informed consent was obtained from all participating adults and from parents or legal guardians for minors or incapacitated adults, together with the manner in which informed consent was obtained (i.e., oral or written).
For animals used in experiments, state the species, strain, number used, and other pertinent descriptive characteristics. When describing surgical procedures on animals, identify the preanesthetic and anesthetic agents used, and state the amount or concentration and the route and frequency of administration for each. The use of paralytic agents, such as curare or succinylcholine, is not an acceptable substitute for anesthetics. For other invasive procedures on animals, report the analgesic or tranquilizing drugs used. If none were used, provide justification for such exclusion. Manuscripts involving animals must indicate that the study was approved by an institutional animal care and use committee. Reports of studies on animals must indicate that the procedures followed were in accordance with institutional guidelines.
Identification of Patients in Descriptions, Photographs and Pedigrees
A signed statement of informed consent to publish (in print and online) patient descriptions, photographs and pedigrees should be obtained from all persons (parents or legal guardians for minors) who can be identified (including by the patients themselves) in such written descriptions, photographs or pedigrees. Such persons should be shown the manuscript before its submission. Omitting data or making data less specific to de-identify patients is acceptable, but changing any such data is not acceptable. State explicitly in the methods section of the manuscript that informed consent was obtained from all participating adult subjects or from parents or legal guardians for minors or incapacitated adults, together with the manner in which informed consent was obtained (i.e., oral or written).
Submitted manuscripts are considered with the understanding that they have not been published previously in print or electronic format (except in abstract or poster form) and are not under consideration in totality or in part by another publication or electronic medium.
Manuscripts should be written in clear, grammatically correct English, using American English spelling, and meet the following basic criteria: the material is original, the information is important, the writing is clear and concise, the study methods are appropriate, the data are valid, and the conclusions are reasonable and supported by the data.
Please see our information pages on Ethics in publishing and Ethical guidelines for journal publication.
Articles covering human or animal experiments must be accompanied by a letter of approval from the relevant review committee or authorities
For human or animal experimental investigations, appropriate institutional review board or ethics committee approval is required, and such approval should be stated in the methods section of the manuscript. For those investigators who do not have formal ethics review committees, the principles outlined in the Declaration of Helsinki should be followed (World Medical Association. Declaration of Helsinki: ethical principles for medical research involving human subjects. Available at http://www.wma.net/en/30publications/10policies/b3/17c.pdf).For investigations of humans, state explicitly in the methods section of the manuscript that informed consent was obtained from all participating adult subjects and from parents or legal guardians for minors or incapacitated adults, together with the manner in which informed consent was obtained (i.e., oral or written).
Human and animal rights
If the work involves the use of human subjects, the author should ensure that the work described has been carried out in accordance with The Code of Ethics of the World Medical Association (Declaration of Helsinki) for experiments involving humans; Uniform Requirements for manuscripts submitted to Biomedical journals. Authors should include a statement in the manuscript that informed consent was obtained for experimentation with human subjects. The privacy rights of human subjects must always be observed.
Declaration of interest
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. Examples of potential competing interests include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. Authors must disclose any interests in two places: 1. A summary declaration of interest statement in the title page file (if double-blind) or the manuscript file (if single-blind). If there are no interests to declare then please state this: 'Declarations of interest: none'. This summary statement will be ultimately published if the article is accepted. 2. Detailed disclosures as part of a separate Declaration of Interest form, which forms part of the journal's official records. It is important for potential interests to be declared in both places and that the information matches. More information.
Submission of an article implies that the work described has not been published previously (except in the form of an abstract, a published lecture or academic thesis, see 'Multiple, redundant or concurrent publication' for more information), that it is not under consideration for publication elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published elsewhere in the same form, in English or in any other language, including electronically without the written consent of the copyright-holder. To verify originality, your article may be checked by the originality detection service Crossref Similarity Check.
Changes to Authorship
This policy concerns the addition, deletion, or rearrangement of author names in the authorship of accepted manuscripts. Before the accepted manuscript is published online, requests to add or remove an author, or to rearrange the author names, must be sent to the Journal Manager from the corresponding author of the accepted manuscript and must include: (i) the reason the name should be added or removed, or the author names rearranged; and (ii) an updated Authorship Statement with signatures from all authors that they agree with the addition, removal or rearrangement. In the case of addition or removal of author names, this must include confirmation from the author(s) being added or removed. Requests that are not sent by the corresponding author will be forwarded by the Journal Manager to the corresponding author, who must follow the procedures as described above.
After the accepted manuscript is published online, any requests to add, remove, or rearrange author names in an article will follow the same policies as detailed above and result in a corrigendum.Reporting clinical trials
Randomized controlled trials should be presented according to the CONSORT guidelines. At manuscript submission, authors must provide the CONSORT checklist accompanied by a flow diagram that illustrates the progress of patients through the trial, including recruitment, enrollment, randomization, withdrawal and completion, and a detailed description of the randomization procedure. The CONSORT checklist and template flow diagram are available online.
Upon acceptance of an article, authors will be asked to complete a 'Journal Publishing Agreement' (see more information on this). An e-mail will be sent to the corresponding author confirming receipt of the manuscript together with a 'Journal Publishing Agreement' form or a link to the online version of this agreement.
As an author you (or your employer or institution) have certain rights to reuse your work. More information.
The IJGE is the official peer-reviewed publication of the Taiwan Society of Geriatric Emergency and Critical Care Medicine. Manuscripts published in the IJGE become the permanent property of the Taiwan Society of Geriatric Emergency and Critical Care Medicine. All articles published in the Journal are protected by copyright, which covers the exclusive rights to reproduce and distribute the article, as well as translation rights. No IJGE article, in part or whole, may be reproduced, stored in any retrieval system, or transmitted in any form or by any means, electronic, mechanical, by photocopying, recording, or otherwise, without prior written permission from the Taiwan Society of Geriatric Emergency and Critical Care Medicine.
As an author you (or your employer or institution) have certain rights to reuse your work. For more information on author rights please see https://www.elsevier.com/copyright.
Find out how you can share your research published in Elsevier journals.
This Journal is a peer reviewed, subsidized open access journal where Taiwan Society of Geriatric Emergency and Critical Care Medicine pays for the publishing costs incurred by the Journal.
Creative Commons Attribution-NonCommercial-NoDerivs (CC BY-NC-ND)
For non-commercial purposes, lets others distribute and copy the article, and to include in a collective work (such as an anthology), as long as they credit the author(s) and provided they do not alter or modify the article.
A signed statement of informed consent to publish (in print and online) patient descriptions, photographs and pedigrees should be obtained from all subjects (parents or legal guardians for minors) who can be identified (including by the subjects themselves) in such written descriptions, photographs or pedigrees. Such persons should be shown the manuscript before its submission. Omitting data or making data less specific to de-identify patients is acceptable, but changing any such data is not acceptable. State explicitly in the methods section of the manuscript that informed consent was obtained from all participating adult subjects or from parents or legal guardians for minors or incapacitated adults, together with the manner in which informed consent was obtained (i.e., oral or written).
Submit your article
Please submit your article via https://www.evise.com/profile/api/navigate/null.
This journal operates a single blind review process. All contributions are typically sent to a minimum of one independent expert reviewer to assess the scientific quality of the paper. The Editor is responsible for the final decision regarding acceptance or rejection of articles. The Editor's decision is final. More information on types of peer review.
It is important that the file be saved in the native format of the word processor used. The text should be in single-column format. Keep the layout of the text as simple as possible. Most formatting codes will be removed and replaced on processing the article. In particular, do not use the word processor's options to justify text or to hyphenate words. However, do use bold face, italics, subscripts, superscripts etc. When preparing tables, if you are using a table grid, use only one grid for each individual table and not a grid for each row. If no grid is used, use tabs, not spaces, to align columns. The electronic text should be prepared in a way very similar to that of conventional manuscripts (see also the Guide to Publishing with Elsevier). Note that source files of figures, tables and text graphics will be required whether or not you embed your figures in the text. See also the section on Electronic artwork.
To avoid unnecessary errors you are strongly advised to use the 'spell-check' and 'grammar-check' functions of your word processor.
Title PageThe title page should contain the following information (in order, from the top to bottom of the page):
Abstract and KeywordsA concise and factual abstract and relevant keywords (in alphabetical order) are required for the following article categories: Review Articles, Original Articles, Brief Communications, and Case Reports.
Abstracts for Original Articles should be structured using the following sections:
An abstract is often presented separately from the article, so it must be able to stand alone. For this reason, references should be avoided, but if essential, then cite the author(s) and year(s). Also, non-standard or uncommon abbreviations should be avoided, but if essential they must be defined at their first mention in the abstract itself.Keywords will be used for indexing purposes and should be taken from the Medical Subject Headings (MeSH) list of Index Medicus (www.nlm.nih.gov/mesh/meshhome.html). Avoid general and plural terms and multiple concepts (avoid, for example, "and", "of"). Be sparing with abbreviations: only abbreviations firmly established in the field may be eligible.
No abstract or keywords are required for Medical Images and Letters to the Editor.Main Text
The text for Original Articles should be organized into the following sections: Introduction, Patients (or Materials) and Methods, Results, Discussion, Acknowledgments (if any), and References. Sections for Case Reports are: Introduction, Case Report, Discussion, Acknowledgments (if any), and References. Each section should begin on a new page.Abbreviations
Where a term/definition will be continually referred to, it must be written in full when it first appears in the text, followed by the subsequent abbreviation in parentheses (even if it was previously defined in the abstract). Thereafter, the abbreviation may be used. An abbreviation should not be first defined in any section heading; if an abbreviation has previously been defined in the text, then the abbreviation may be used in a subsequent section heading. Restrict the number of abbreviations to those that are absolutely necessary and ensure consistency of abbreviations throughout the article. Ensure that an abbreviation so defined does actually appear later in the text (excluding in figures/tables), otherwise, it should be deleted.
UnitsSystme International (SI) units must be used, with the exception of blood pressure values which are to be reported in mmHg. Use the metric system for the expression of length, area, mass, and volume. Temperatures are to be given in degrees Celsius.
Names of drugs, devices and other productsUse the Recommended International Non-proprietary Name (rINN) for medicinal substances, unless the specific trade name of a drug is directly relevant to the discussion. Generic drug names should appear in lowercase letters in the text. If a specific proprietary drug needs to be identified, the brand name may appear only once in the manuscript in parentheses following the generic name the first time the drug is mentioned in the text. For devices and other products, the specific brand or trade name, the manufacturer and their location (city, state, country) should be provided the first time the device or product is mentioned in the text, for example, "...KIBM SPSS Statistics 21.0 was used (IBM Corp., Armonk, NY, USA)". Thereafter, the generic term (if appropriate) should be used.
Gene nomenclatureCurrent standard international nomenclature for genes should be adhered to. For human genes, use genetic notation and symbols approved by the HUGO Gene Nomenclature Committee ( www.genenames.org). You may also refer to the resources available on PubMed at www.ncbi.nlm.nih.gov/guide/genes-expression. The Human Genome Variation Society has a useful site that provides guidance in naming mutations at www.hgvs.org/mutnomen/index.html. In your manuscript, genes should be typed in italic font and include the accession number.
Statistical requirementsStatistical analysis is essential for all research papers except Case Reports. Use correct nomenclature for statistical methods (e.g., two sample t test, not unpaired t test). Descriptive statistics should follow the scales used in data description. Inferential statistics are important for interpreting results and should be described in detail.
All p values should be presented to the third decimal place for accuracy. The smallest p value that should be expressed is p < 0.001 since additional zeros do not convey useful information; the largest p value that should be expressed is p > 0.99.Personal communications and unpublished data
These sources cannot be included in the references list but may be described in the text. The author(s) must give the full name and highest academic degree of the person, the date of the communication, and indicate whether it was in oral or written (letter, fax, e-mail) form. A signed statement of permission should be included from each person identified as a source of information in a personal communication or as a source for unpublished data.Acknowledgements
General acknowledgments for consultations and statistical analyses should be listed concisely, including the names of the individuals who were directly involved. Consent should be obtained from those individuals before their names are listed in this section. Those acknowledged should not include secretarial, clerical or technical staff whose participation was limited to the performance of their normal duties.
All financial and material support for the research, work, writing and editorial assistance from internal or external agencies, including commercial companies, should be clearly and completely identified in a Funding/Support Statement.
Please make sure that artwork files are in an acceptable format (TIFF (or JPEG), EPS (or PDF), or MS Office files) and with the correct resolution. If, together with your accepted article, you submit usable color figures then Elsevier will ensure, at no additional charge, that these figures will appear in color online (e.g., ScienceDirect and other sites) regardless of whether or not these illustrations are reproduced in color in the printed version. For color reproduction in print, you will receive information regarding the costs from Elsevier after receipt of your accepted article. Please indicate your preference for color: in print or online only. Further information on the preparation of electronic artwork.
Tables should supplement, not duplicate, the text. They should have a concise table heading, be self-explanatory, and numbered consecutively in the order of their citation in the text. Information requiring explanatory footnotes should be denoted using superscripted lowercase letters (a, b, c, etc.), with the footnotes arranged under the table in alphabetical order. Asterisks (*, **) are used only to indicate the probability level of tests of significance. Abbreviations used in the table must be defined and placed after the footnotes in alphabetical order. If you include a block of data or table from another source, whether published or unpublished, you must acknowledge the original source.
The number of figures should be restricted to the minimum necessary to support the textual material. Figures should have an informative figure legend and be numbered in the order of their citation in the text. All symbols and abbreviations should be defined in the figure legend in alphabetical order. Items requiring explanatory footnotes should follow the same style as that for tables as described.
Unless you have written permission from the patient (or, where applicable, the next of kin), the personal details (such as name and date of birth) of the patient must be removed. Anything that might allow identification of a patient must be obscured (e.g., if their face is shown, use a black bar to cover their eyes so that they cannot be identified; for further information, see External link http://www.elsevier.com/about/policies/author-agreement/obtaining-permission#policy-patient-photographs). If this is not possible or the patient can be identified in some other way, written consent from the patient or family must be submitted along with the article.All lettering should be done professionally and should be in proportion to the drawing, graph or photograph. Photomicrographs must include an internal scale marker, and the legend should state the type of specimen, original magnification and stain.
Figures must be submitted as separate picture files, at the correct resolution and named according to the figure number and format, e.g., "Fig1.tif", "Fig2.jpg".References
Authors are responsible for the accuracy and completeness of their references and for correct in-text citation.
1. In the main text, tables and figure legends
- References should be limited to those cited in the text only.
- The surnames and initials of all the authors up to 3 should be included, but when there are more than 3 authors, list the first 3 authors only followed by "et al".
- Journal references should include, in order, authors' surnames and initials, article title, abbreviated journal name, year, volume and inclusive page numbers
- Abbreviations for journal names should conform to those used in MEDLINE.
- References to books should include the authors' last names and initials, complete title of the chapter, names of the book's editors, complete title of the book, city of publication, publisher, volume and edition numbers, year of publication, and the inclusive page numbers of the cited chapter.
- References to websites should include the authors' names, article title, URL, and the date you last accessed the information.
Standard journal article
Chen CY, Chuang SY, Fang CC, et al. Gender difference in statin intervention on blood lipid control among patients with coronary heart disease. Int J Gerontol. 2013;7:116-121.
Kaplan NM. The endothelium as prognostic factor and therapeutic target: what criteria should we apply? J Cardiovasc Pharmacol. 1998;32(Suppl 3):S78-80.
Kawai H, Ishikawa T, Moroi J, et al. Elderly patient with cerebellar malignant astrocytoma. No Shinkei Geka. 2008;36:799-805. [In Japanese, English abstract]
Book with edition
Bradley EL. Medical and Surgical Management. 2nd ed. Philadelphia, PA: WB Saunders; 1982.
Adkinson N, Yunginger J, Busse W, et al, eds. Middleton's Allergy: Principles and Practice. 6th ed. St Louis, MO: Mosby; 2003.
Book chapter in book with editor and edition
Levitt MD. Pancreatitis. In: Sleisenger MH, ed. Cecil Textbook of Medicine. 18th ed. Philadelphia, PA: WB Saunders; 1988:774-780.
Wilson JG, Fraser FC, eds. Handbook of Teratology, Vols. 1-4. New York, NY: Plenum Press; 1977-1978.
Substance Abuse and Mental Health Services Administration. Emergency Department Trends from the Drug Abuse Warning Network, Final Estimates 1995-2002. Rockville, MD: Substance Abuse and Mental Health Services Administration, Office of Applied Statistics; 2003.
Duchin JS. Can preparedness for biological terrorism save us from pertussis? Arch Pediatr Adolesc Med. 2004;158(2). Available at http://archpedi.ama-assn.org/cgi/content/full/158/2/106. Accessed June 12, 2004.
Smeeth L, Iliffe S. Community screening for visual impairment in the elderly. Cochrane Database Syst Rev. 2002(2):CD001054. Doi:10.1002/14651858.CD1001054.Thesis
Griffiths P. Nursing Patients in Transition: An Ethnography of the Role of the Nurse on an Acute Medical Admissions Unit. PhD thesis. Wales, UK: University of Wales; 2007.
NICE-National Institute for Health and Care Excellence. Acute Upper Gastrointestinal Bleeding: Management (CG141). London, UK: NICE; 2012. Available at http://publications.nice.org.uk/acute-upper-gastrointestinal-bleeding-management-cg141. Accessed April 15, 2013.
Eastman Kodak Company, Eastman Organic Chemicals. Catalog No. 49. Rochester, NY: Eastman Kodak; 1977:2-3.
Citation in text
Please ensure that every reference cited in the text is also present in the reference list (and vice versa). Any references cited in the abstract must be given in full. Unpublished results and personal communications are not recommended in the reference list, but may be mentioned in the text. If these references are included in the reference list they should follow the standard reference style of the journal and should include a substitution of the publication date with either 'Unpublished results' or 'Personal communication'. Citation of a reference as 'in press' implies that the item has been accepted for publication.
This journal encourages you to cite underlying or relevant datasets in your manuscript by citing them in your text and including a data reference in your Reference List. Data references should include the following elements: author name(s), dataset title, data repository, version (where available), year, and global persistent identifier. Add [dataset] immediately before the reference so we can properly identify it as a data reference. The [dataset] identifier will not appear in your published article.
This journal encourages and enables you to share data that supports your research publication where appropriate, and enables you to interlink the data with your published articles. Research data refers to the results of observations or experimentation that validate research findings. To facilitate reproducibility and data reuse, this journal also encourages you to share your software, code, models, algorithms, protocols, methods and other useful materials related to the project.
If you have made your research data available in a data repository, you can link your article directly to the dataset. Elsevier collaborates with a number of repositories to link articles on ScienceDirect with relevant repositories, giving readers access to underlying data that gives them a better understanding of the research described.
For supported data repositories a repository banner will automatically appear next to your published article on ScienceDirect.In addition, you can link to relevant data or entities through identifiers within the text of your manuscript, using the following format: Database: xxxx (e.g., TAIR: AT1G01020; CCDC: 734053; PDB: 1XFN).
This journal supports Mendeley Data, enabling you to deposit any research data (including raw and processed data, video, code, software, algorithms, protocols, and methods) associated with your manuscript in a free-to-use, open access repository. During the submission process, after uploading your manuscript, you will have the opportunity to upload your relevant datasets directly to Mendeley Data. The datasets will be listed and directly accessible to readers next to your published article online.
To foster transparency, we encourage you to state the availability of your data in your submission. This may be a requirement of your funding body or institution. If your data is unavailable to access or unsuitable to post, you will have the opportunity to indicate why during the submission process, for example by stating that the research data is confidential. The statement will appear with your published article on ScienceDirect. For more information, visit the Data Statement page.
As a general rule, the receipt of a manuscript will be acknowledged within 2 weeks of submission, and authors will be provided with a manuscript reference number for future correspondence. If such an acknowledgment is not received in a reasonable period of time, the author should contact the Editorial Office.
Submissions are reviewed by the Editorial Office to ensure that it contains all parts. Submissions will be rejected if the author has not supplied all the material and documents as outlined in these author instructions.Manuscripts are then forwarded to the Editor-in-Chief, who makes an initial assessment of it. If the manuscript does not appear to be of sufficient merit or is not appropriate for the Journal, then the manuscript will be rejected without review.
Manuscripts that appear meritorious and appropriate for the Journal are reviewed by at least two Editorial Board members or expert consultants assigned by the Editor-in-Chief. The IJGE follows a double-blind peer review process. Authors may submit a list in their cover letter of reviewers who they wish to review or not to review their manuscript. However, the actual peer reviewers invited will remain anonymous and may or may not be the reviewers suggested by the authors as the selection of reviewers is at the sole discretion of IJGE Editors.The corresponding author will usually be notified within 12 weeks of whether the submitted article is accepted for publication, rejected, or subject to revision before acceptance (however, do note that delays are sometimes unavoidable). If revisions are required, authors are asked to return a revised manuscript to the Editorial Office via the EES within 30 days. Please notify the Editorial Office in advance if additional time is needed or if you choose not to submit a revised manuscript.
Preparation for Publication
Once a manuscript has been accepted for publication, authors should submit the final version of their manuscript in MS Word format, with all tables/figures as applicable, via EVISE.
Proofreading is solely the authors' responsibility. Note that the Editorial Board reserves the right to make revisions to the manuscript and the Publisher may proceed with the publication of your article if no response from the author(s) is received.Publication Charges and Reprints
Authors of accepted articles will be charged a publication fee as follows:
For this journal an optional QUICK PUBLICATION service is available to authors for their accepted manuscripts.
Quick publication service allows the accepted manuscript to appear in the next 1 or 2 coming print issue, depending on the availability, of the journal.
Authors who opt for this service is responsible for arranging the payment and replying author proofs within one week. The handling fee of US$300/NT$10,000 will be additionally charged for all categories of article.
Corresponding authors will receive an e-mail with a link to our online proofing system, allowing annotation and correction of proofs online. The environment is similar to MS Word: in addition to editing text, you can also comment on figures/tables and answer questions from the Copy Editor. Web-based proofing provides a faster and less error-prone process by allowing you to directly type your corrections, eliminating the potential introduction of errors.
If preferred, you can still choose to annotate and upload your edits on the PDF version. All instructions for proofing will be given in the e-mail we send to authors, including alternative methods to the online version and PDF.
We will do everything possible to get your article published quickly and accurately. Please use this proof only for checking the typesetting, editing, completeness and correctness of the text, tables and figures. Significant changes to the article as accepted for publication will only be considered at this stage with permission from the Editor. It is important to ensure that all corrections are sent back to us in one communication. Please check carefully before replying, as inclusion of any subsequent corrections cannot be guaranteed. Proofreading is solely your responsibility.
The corresponding author, at no cost, will be provided with a PDF file of the article via e-mail (the PDF file is a watermarked version of the published article and includes a cover sheet with the journal cover image and a disclaimer outlining the terms and conditions of use). For an extra charge, paper offprints can be ordered via the offprint order form which is sent once the article is accepted for publication. Both corresponding and co-authors may order offprints at any time via Elsevier's WebShop. Authors requiring printed copies of multiple articles may use Elsevier WebShop's 'Create Your Own Book' service to collate multiple articles within a single cover.
Visit the Elsevier Support Center to find the answers you need. Here you will find everything from Frequently Asked Questions to ways to get in touch.
You can also check the status of your submitted article or find out when your accepted article will be published. FORMS